Basic Information

Faculty

• 薬学部

Professional Memberships

• The Pharmaceutical Society of Japan
• Japanese Society of Pharmaceutical Health Care and Sciences
• Japanese Society for Pharmacoepidemiology
• Society for Clinical Epidemiology
• Japan Society for Pharmaceutics Education

Academic Degree

• (Kyoto University)
• (Kyoto University)

Academic Resume (Graduate Schools)

• Kyoto University, 大学院薬学研究科修士課程医療薬科学専攻, 修了
• Kyoto University, 大学院薬学研究科博士後期課程医療薬科学専攻, 修了

Academic Resume (Undergraduate School/Majors)

• Kyoto University, 薬学部総合薬学科, 卒業

High School

• High School

  愛知県立一宮高等学校

Research History

• From Apr. 2023, To Present

  京都大学大学院薬学研究科, 准教授
• From 01 Oct. 2017

  Graduate School of Pharmaceutical Sciences, Kyoto University, Lecture
• From 01 Apr. 2015

  Graduate School of Pharmaceutical Sciences, Kyoto University, Senior Lecturer
• From 01 Apr. 2010

  Department of Pharmacy, Kyoto University Hospital, Pharmacist
• From 01 Apr. 2007

  Research Fellow of the Japan Society for the Promotion of Science, Research Fellowships for Young Scientists

Profile

• Profile

  My research theme is the elucidation of the mechanism of pharmacokinetics and pharmacodynamics and its application to personalized medicine. As for education, I am in charge of lectures and exercises on clinical subjects. In addition to engaging in research and education at the university, I also work as a pharmacist at the department of pharmacy in Kyoto University Hospital.

Language of Instruction

• Japanese

ID,URL

• ORCID ID

  0000-0001-9474-5107

• J-Global ID

  201501040919641875

researchmap URL

• https://researchmap.jp/7000011352

Research

Research Topics, Overview of the research

• Research Topics

  Elucidation of mechanism of the variance of pharmacokinetics and drug efficacy, Application to personalized medicine

• Overview of the research

  I analyze the mechanism of changes in pharmacokinetics and efficacy by conducting functional analysis of drug transporters, and conduct research aimed at the practice of personalized medicine where the optimum drug administration is designed for the individual based on such information.

Research Interests

• Clinical Pharmaceutics
• Pharmacokinetics

Research Areas

• Life sciences, Clinical pharmacy

Papers

• Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study

  Mari Yokoi; Atsushi Yonezawa; Daiki Hira; Tomohiro Handa; Kiminobu Tanizawa; Shunsaku Nakagawa; Masahiro Tsuda; Yasuaki Ikemi; Ryo Itotani; Hironori Yoshida; Motoo Nomura; Junichi Matsubara; Kosaku Murakami; Hiroaki Ozasa; Manabu Muto; Tomohiro Terada

  Journal of Pharmaceutical Health Care and Sciences, 27 Aug. 2024, Peer-reviewed

  
• Model-Informed Dosing Optimization of Tacrolimus for Concomitant Administration with Itraconazole to Japanese Lung Transplant Recipients.

  Ren Takahashi; Kotaro Itohara; Shunsaku Nakagawa; Yoshiki Katada; Mitsuhiro Sugimoto; Keisuke Umemura; Katsuyuki Matsumura; Daiki Hira; Masahiro Tsuda; Yurie Katsube; Satona Tanaka; Akihiro Ohsumi; Daisuke Nakajima; Miki Nagao; Hiroshi Date; Tomohiro Terada

  Therapeutic drug monitoring, 06 Aug. 2024, Peer-reviewed

  
• DECREASED RENAL SECRETION OF METFORMIN IN MULTIDRUG AND TOXIN EXTRUSION 1 (Mate1) KNOCKOUT MICE

  Tsuda Masahiro; Terada Tomohiro; Mizuno Tomoyuki; Katsura Toshiya; Shimakura Jin; Inui Ken-ichi

  Abstracts of Annual meeting of Japanese Society for the Study of Xenobiotics, 2009

  
• Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series.

  Hanako Naganawa; Yoshiki Katada; Shunsaku Nakagawa; Keisuke Umemura; Hiroki Ishimura; Moto Kajiwara; Hiroki Endo; Mitsuhiro Sugimoto; Yurie Katsube; Kinuka Kotani; Saki Ohta; Daiki Hira; Masahiro Tsuda; Yuki Kita; Takashi Kobayashi; Tomohiro Terada

  Journal of pharmaceutical health care and sciences, 10 Jul. 2024

  
• A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient.

  Yoshiki Katada; Keisuke Umemura; Shunsaku Nakagawa; Yurie Katsube; Masahiro Tsuda; Satona Tanaka; Hiroshi Date; Miki Nagao; Tomohiro Terada

  Journal of pharmaceutical health care and sciences, 07 Jun. 2024

  
• Perfluoropolyether-Based Gut-Liver-on-a-Chip for the Evaluation of First-Pass Metabolism and Oral Bioavailability of Drugs

  Mengyang Wang; Yuko Sasaki; Rena Sakagami; Tomotaka Minamikawa; Masahiro Tsuda; Ryohei Ueno; Sayaka Deguchi; Ryosuke Negoro; Kanako So; Yuriko Higuchi; Ryuji Yokokawa; Kazuo Takayama; Fumiyoshi Yamashita

  ACS Biomaterials Science and Engineering, 2024

  
• Relationship between Adsorption and Toxicity of Nephrotoxic Drugs in Microphysiological Systems (MPS)

  Ryohei Ueno; Masahiro Kuninori; Takumi Sumi; Ramin Banan Sadeghian; Yuji Takata; Azusa Iguchi; Masahiro Tsuda; Fumiyoshi Yamashita; Kentaro Ichikawa; Ryuji Yokokawa

  Micromachines, 29 Mar. 2023

  
• Application of perfluoropolyether elastomers in microfluidic drug metabolism assays.

  Mengyang Wang; Masahiro Tsuda; Sayaka Deguchi; Yuriko Higuchi; Kanako So; Yu-Suke Torisawa; Kazuo Takayama; Fumiyoshi Yamashita

  International journal of pharmaceutics, 05 Nov. 2022

  
• Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.

  Yuko Sasaki; Hirotaka Tatsuoka; Masahiro Tsuda; Takumi Sumi; Yuka Eguchi; Kanako So; Yuriko Higuchi; Kazuo Takayama; Yusuke Torisawa; Fumiyoshi Yamashita

  Biological & pharmaceutical bulletin, 2022, Peer-reviewed, Corresponding author

  
• CREB is a potential marker associated with drug-induced liver injury: Identification and validation through transcriptome database analysis

  Qiyue Zhang; Shiori Taniguchi; Kanako So; Masahiro Tsuda; Yuriko Higuchi; Mitsuru Hashida; Fumiyoshi Yamashita

  JOURNAL OF TOXICOLOGICAL SCIENCES, 2022, Peer-reviewed

  
• Effect of Itraconazole and Its Metabolite Hydroxyitraconazole on the Blood Concentrations of Cyclosporine and Tacrolimus in Lung Transplant Recipients.

  Yuya Matsuda; Shunsaku Nakagawa; Ikuko Yano; Satohiro Masuda; Satoshi Imai; Atsushi Yonezawa; Takashi Yamamoto; Mitsuhiro Sugimoto; Masahiro Tsuda; Tetsunori Tsuzuki; Tomohiro Omura; Takayuki Nakagawa; Toyofumi Fengshi Chen-Yoshikawa; Miki Nagao; Hiroshi Date; Kazuo Matsubara

  Biological & pharmaceutical bulletin, 2022, Peer-reviewed

  
• Generation of Tetrafluoroethylene-Propylene Elastomer-Based Microfluidic Devices for Drug Toxicity and Metabolism Studies.

  Emi Sano; Sayaka Deguchi; Naoki Matsuoka; Masahiro Tsuda; Mengyang Wang; Kaori Kosugi; Chihiro Mori; Keisuke Yagi; Aya Wada; Shinsuke Yamasaki; Tsuyoshi Kawai; Masahide Yodogawa; Hiroyuki Mizuguchi; Norihito Nakazawa; Fumiyoshi Yamashita; Yu-Suke Torisawa; Kazuo Takayama

  ACS omega, 28 Sep. 2021, Peer-reviewed

  Access this paper :

  
• Usability of Polydimethylsiloxane-Based Microfluidic Devices in Pharmaceutical Research Using Human Hepatocytes.

  Sayaka Deguchi; Masahiro Tsuda; Kaori Kosugi; Ayaka Sakamoto; Natsumi Mimura; Ryosuke Negoro; Emi Sano; Takuro Nobe; Kazuya Maeda; Hiroyuki Kusuhara; Hiroyuki Mizuguchi; Fumiyoshi Yamashita; Yu-Suke Torisawa; Kazuo Takayama

  ACS biomaterials science & engineering, 09 Aug. 2021, Peer-reviewed

  
• Prediction of HIV drug resistance based on the 3D protein structure: Proposal of molecular field mapping.

  Ryosaku Ota; Kanako So; Masahiro Tsuda; Yuriko Higuchi; Fumiyoshi Yamashita

  PloS one, 2021, Peer-reviewed

  
• 体重に応じたテイコプラニン初期投与設計の有効性と安全性に関する検討

  片田 佳希; 中川 俊作; 山嶋 仁実; 杉本 充弘; 木全 柾典; 吉田 優子; 松田 裕也; 髙橋 悠; 糸原 光太郎; 北田 徳昭; 今井 哲司; 深津 祥央; 津田 真弘; 米澤 淳; 中川 貴之; 山本 正樹; 松村 康史; 長尾 美紀; 松原 和夫

  日本化学療法学会雑誌, Nov. 2020, Peer-reviewed

  
• A model-based comparative meta-analysis of the efficacy of dolutegravir-based and efavirenz-based regimens in HIV-infected patients.

  Ota R; Ishii H; Tsuda M; Higuchi Y; Yamashita F

  Journal of infection and chemotherapy, Sep. 2019, Peer-reviewed

  
• Sialyl LewisX mimic-decorated liposomes for anti-angiogenic everolimus delivery to E-selectin expressing endothelial cells

  Chantarasrivong Chanikarn; Higuchi Yuriko; Tsuda Masahiro; Yamane Yuuki; Hashida Mitsuru; Konishi Miku; Komura Naoko; Ando Hiromune; Yamashita Fumiyoshi

  RSC ADVANCES, 04 Jul. 2019, Peer-reviewed

  Access this paper :

  
• Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin's Lymphoma.

  Atushi Yonezawa; Yuki Otani; Toshiyuki Kitano; Mayuko Mori; Sho Masui; Yui Isomoto; Masahiro Tsuda; Satoshi Imai; Yasuaki Ikemi; Masaya Denda; Yuki Sato; Shunsaku Nakagawa; Tomohiro Omura; Takayuki Nakagawa; Ikuko Yano; Makoto Hayakari; Akifumi Takaori-Kondo; Kazuo Matsubara

  Pharmaceutical research, 15 Apr. 2019, Peer-reviewed

  Access this paper :

  
• Analysis of Glycoforms and Amino Acids in Infliximab and a Biosimilar Product Using New Method with LC/TOF-MS.

  Tsuda M; Otani Y; Yonezawa A; Masui S; Ikemi Y; Denda M; Sato Y; Nakagawa S; Omura T; Imai S; Nakagawa T; Hayakari M; Matsubara K

  Biological & pharmaceutical bulletin, Nov. 2018, Peer-reviewed, Lead author

  
• An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis

  Fumiyoshi Yamashita; Atsuto Fujita; Yukako Sasa; Yuriko Higuchi; Masahiro Tsuda; Mitsuru Hashida

  JOURNAL OF PHARMACEUTICAL SCIENCES, Sep. 2017, Peer-reviewed

  
• Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats

  Yuki Otani; Atushi Yonezawa; Masahiro Tsuda; Satoshi Imai; Yasuaki Ikemi; Shunsaku Nakagawa; Tomohiro Omura; Takayuki Nakagawa; Ikuko Yano; Kazuo Matsubara

  PLOS ONE, Jan. 2017, Peer-reviewed

  Access this paper :

  
• Qualitative Component Analysis of Filgrastim Biosimilars by LC/QTOF-MS

  松村健吾; 大谷祐基; 大村友博; 米澤淳; 津田真弘; 池見泰明; 中川俊作; 今井哲司; 中川貴之; 矢野育子; 吉貴達寛; 松原和夫

  医療薬学, Sep. 2016, Peer-reviewed

  
• Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data

  Satoko Ito; Ikuko Yano; Sachiyo Hashi; Masahiro Tsuda; Mitsuhiro Sugimoto; Atsushi Yonezawa; Akio Ikeda; Kazuo Matsubara

  THERAPEUTIC DRUG MONITORING, Jun. 2016, Peer-reviewed

  
• Everolimus blood concentrations did not predict interstitial lung disease in patients with metastatic renal cell carcinoma

  Shinsako Keiko; Yano Ikuko; Tanaka Atsuko; Fukudo Masahide; Tsuda Masahiro; Sato Eriko; Kobayashi Takashi; Yamasaki Toshinari; Okubo Kazutoshi; Kamba Tomomi; Yoshimura Koji; Ogawa Osamu; Matsubara Kazuo

  TDM研究, Mar. 2016, Peer-reviewed

  
• プロトコルに基づいた薬物治療管理の臨床アウトカム評価 TDMオーダを含めたバンコマイシン処方設計支援

  片田 佳希; 中川 俊作; 田上 裕美; 津田 真弘; 都築 徹教; 端 幸代; 小高 瑞穂; 米澤 淳; 萱野 勇一郎; 矢野 育子; 南方 謙二; 坂田 隆造; 松原 和夫

  医療薬学, Jan. 2016, Peer-reviewed

  
• 薬剤師による処方設計 外来がん化学療法におけるトレーシングレポートを活用した病診薬連携の取り組み

  津田 真弘; 礒本 唯; 萱野 勇一郎; 矢野 育子; 松原 和夫

  医薬ジャーナル, Nov. 2014

  
• Reduced Renal Clearance of a Zwitterionic Substrate Cephalexin in Mate1-Deficient Mice

  Shingo Watanabe; Masahiro Tsuda; Tomohiro Terada; Toshiya Katsura; Ken-ichi Inui

  JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, Aug. 2010, Peer-reviewed

  
• Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients

  Kana Toyama; Atsushi Yonezawa; Masahiro Tsuda; Satohiro Masuda; Ikuko Yano; Tomohiro Terada; Riyo Osawa; Toshiya Katsura; Masaya Hosokawa; Shimpei Fujimoto; Nobuya Inagaki; Ken-Ichi Inui

  PHARMACOGENETICS AND GENOMICS, Feb. 2010, Peer-reviewed

  
• Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin

  Masahiro Tsuda; Tomohiro Terada; Tomoyuki Mizuno; Toshiya Katsura; Jin Shimakura; Ken-ichi Inui

  MOLECULAR PHARMACOLOGY, Jun. 2009, Peer-reviewed, Lead author

  
• Involvement of Human Multidrug and Toxin Extrusion 1 in the Drug Interaction between Cimetidine and Metformin in Renal Epithelial Cells

  Masahiro Tsuda; Tomohiro Terada; Miki Ueba; Tomoko Sato; Satohiro Masuda; Toshiya Katsura; Ken-ichi Inui

  JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, Apr. 2009, Peer-reviewed, Lead author

  
• Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE)

  Jun-ichi Asaka; Tomohiro Terada; Masahiro Tsuda; Toshiya Katsura; Ken-ichi Inui

  MOLECULAR PHARMACOLOGY, Jun. 2007, Peer-reviewed

  
• Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1

  Masahiro Tsuda; Tomohiro Terada; Jun-ichi Asaka; Miki Ueba; Toshiya Katsura; Ken-ichi Inui

  AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, Feb. 2007, Peer-reviewed, Lead author

  
• Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1

  Tomohiro Terada; Satohiro Masuda; Jun-ichi Asaka; Masahiro Tsuda; Toshiya Katsura; Ken-ichi Inui

  PHARMACEUTICAL RESEARCH, Aug. 2006, Peer-reviewed

  
• Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives

  M Tsuda; T Terada; M Irie; T Katsura; A Niida; K Tomita; N Fujii; K Inui

  JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, Jul. 2006, Peer-reviewed, Lead author

  
• Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels

  M Irie; T Terada; M Tsuda; T Katsura; K Inui

  PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, Apr. 2006, Peer-reviewed

  

Misc.

• 経口バイオアベイラビリティー評価のための腸肝連結マイクロ流体チップの開発

  山下 富義; 王 夢洋; 津田 真弘; 樋口 ゆり子; 高山 和雄

  日本薬剤学会年会講演要旨集, May 2023

  
• 肺移植後におけるバルガンシクロビル経口投与時の血中ガンシクロビルトラフ値と予防効果の後方視的調査

  勝部友理恵; 片田佳希; 片田佳希; 梅村圭祐; 卜部裕月; 平大樹; 津田真弘; 津田真弘; 中川俊作; 大角明宏; 中島大輔; 長尾美紀; 伊達洋至; 寺田智祐

  日本臨床薬理学会学術総会抄録集(Web), 2023

  
• シクロスポリンおよびタクロリムスの血中濃度測定系に対するアゾール系抗真菌薬の影響

  岩上 智香; 津田 真弘; 杉本 充弘; 米澤 淳; 都築 徹教; 松原 惇起; 中川 俊作; 矢野 育子; 中川 貴之; 松原 和夫

  日本薬学会年会要旨集, Mar. 2016

  
• インフリキシマブ先行品と後続品における糖鎖構造の比較

  津田 真弘; 大谷 祐基; 米澤 淳; 池見 泰明; 大村 友博; 中川 俊作; 今井 哲司; 中川 貴之; 矢野 育子; 松原 和夫

  日本薬学会年会要旨集, Mar. 2016

  
• B細胞リンパ腫患者における、リツキシマブのPK/PD解析

  森 万優子; 米澤 淳; 大谷 祐基; 磯本 唯; 津田 真弘; 池見 泰明; 今井 哲司; 大村 友博; 北野 俊行; 高折 晃史; 矢野 育子; 松原 和夫

  臨床薬理, Nov. 2017

  
• Increased gene and functional expression of P-glycoprotein in Caco-2 by streching stress stimulation

  高谷直樹; 津田真弘; 宗可奈子; 樋口ゆり子; 山下富義

  日本薬剤学会年会講演要旨集(CD-ROM), 2022

  
• COVID19による呼吸不全によりECMO管理下に抗HIV療法を継続した症例

  和田 典也; 松村 勝之; 津田 真弘; 尾崎 淳子; 助石 有沙美; 白川 康太郎; 米澤 淳; 甲斐 慎一; 田辺 直也; 伊藤 功朗; 平井 豊博; 高折 晃史

  日本エイズ学会誌, Nov. 2021

  
• Polydimethylsiloxane製liver-on-a-chipを用いた薬物代謝・毒性試験

  出口 清香; 津田 真弘; 小杉 香織; 水口 裕之; 山下 富義; 鳥澤 勇介; 高山 和雄

  The Journal of Toxicological Sciences, Jul. 2021

  
• Prediction of HIV drug resistance by using 3D molecular field mapping

  Fumiyoshi Yamashita; Ryosaku Ohata; Kanako So; Masahiro Tsuda; Yuriko Higuchi

  CSPS/PSJ/CC-CRS 2021 SYMPOSIUM, May 2021

  
• Involvement of P-gp and BCRP in the transfer of integrase inhibitors to the brain

  Masahiro Tsuda; Mizuki Uno; Kanako So; Yuriko Higuchi; Fumiyoshi Yamashita

  CSPS/PSJ/CC-CRS 2021 SYMPOSIUM, May 2021, Lead author

  
• ディープラーニングと拡張非線形最小二乗法を統合した母集団薬物動態モデル化技術の開発

  戸田力也; 楊雪; 津田真弘; 宗可奈子; 樋口ゆり子; 山下富義

  日本薬剤学会第36年会, May 2021

  
• 京都⼤学薬学部における初年次アクティブラーニング科⽬ 「薬学研究SGD演習」の3年⽬の効果検証

  杉山芳生; 松下佳代; 高須清誠; 山下富義; 津田真弘

  第27回⼤学教育研究フォーラム, Mar. 2021

  
• Polydimethylsiloxane製のliver-on-a-chipの薬物動態研究への応用

  出口清香; 津田真弘; 小杉香織; 前田和哉; 楠原洋之; 水口裕之; 山下富義; 鳥澤勇介; 高山和雄

  日本薬学会第141年会, Mar. 2021

  
• ディープニューラルネットワークの臨床母集団薬物動態解析への応用

  戸田力也; 太田亮作; 津田真弘; 山下富義

  第35回日本薬物動態学会, Dec. 2020

  
• マイクロ流体デバイスを用いたin vitro薬物吸収動態評価

  佐々木優子; 龍岡宏孝; 津田真弘; 鳥澤勇介; 山下富義

  日本薬剤学会 第35年会 要旨集, May 2020

  
• 抗HIV薬ドルテグラビルの吸収動態に対する薬物排出トランスポーターBCRPの寄与

  宇野瑞樹; 神谷武志; 津田真弘; 山下富義

  日本薬剤学会 第35年会 要旨集, May 2020

  
• 京都大学薬学部における初年次アクティブラーニング科目 「薬学研究SGD 演習」の2 年目の効果検証

  杉山 芳生; 松下 佳代; 高須 清誠; 山下 富義; 津田 真弘

  第26回大学教育研究フォーラム, Mar. 2020

  
• ディープ・ニューラルネットワークを組み込んだ母集団薬物動態モデルの開発

  山下 富義; 太田 亮作; 津田 真弘; 樋口 ゆり子

  日本薬学会年会要旨集, Mar. 2020

  
• マイクロ流体デバイスを用いた吸収動態評価

  佐々木優子; 龍岡宏孝; 津田真弘; 鳥澤勇介; 三小田亜希子; 川口義弥; 山下富義

  第69回日本薬学会関西支部総会・大会 要旨集, Oct. 2019

  
• 薬物排出トランスボーターBCRP を介したインテグラーゼ阻害薬の輸送評価

  宇野瑞樹、神谷武志、津田真弘、山下富義

  第69回日本薬学会関西支部総会・大会 要旨集, Oct. 2019

  
• 博士人材の育成を目指す京都大学薬学部における初年次アクティブラーニング科目「SGD演習」の試み

  高須清誠; 山下富義; 津田真弘; 柿澤 昌; 矢野義明; 長沼祥太郎; 松下佳代

  第25回大学教育研究フォーラム, Mar. 2019

  
• 京都大学薬学部における初年次アクティブラーニング科目「SDG演習」の効果検証の枠組みの設計

  長沼祥太郎; 松下佳代; 高須清誠; 山下富義; 津田真弘

  第25回大学教育研究フォーラム, Mar. 2019

  
• ヒアルロン酸修飾高分子ナノカプセルによる水溶性薬物のがん細胞内送達

  麻生寛人; 樋口ゆり子; 津田真弘; 山下富義

  第68回日本薬学会近畿支部総会・大会, Oct. 2018

  
• シミュレーターを利用したフィジカルアセスメント実習に対する意識動向の調査

  津田真弘; 宗可奈子; 糀谷康子; 内藤知佐子; 山下富義

  第3回日本薬学教育学会大会 講演要旨集, Sep. 2018

  
• 非ホジキンリンパ腫患者におけるリツキシマブの体内動態と臨床効果の相関

  大谷祐基; 米澤淳; 森万優子; 磯本唯; 津田真弘; 池見泰明; 今井哲司; 中川俊作; 大村友博; 中川貴之; 北野俊行; 高折晃史; 松原和夫

  医療薬学フォーラム講演要旨集, Jun. 2018

  
• B細胞リンパ腫患者における、リツキシマブのPK/PD解析

  森 万優子; 米澤 淳; 大谷 祐基; 磯本 唯; 津田 真弘; 池見 泰明; 今井 哲司; 大村 友博; 北野 俊行; 高折 晃史; 矢野 育子; 松原 和夫

  臨床薬理, Nov. 2017

  
• 参加・体験型実習内容の均等化を目指した２薬局体験型実務実習のトライアル調査

  津田真弘; 大澤史宜; 山下富義

  第27回日本医療薬学会年会 要旨集, Nov. 2017

  
• 質量分析法を駆使した最新薬物動態研究 LC/TOF-MSを用いた抗体医薬品の体内動態解析

  大谷 祐基; 米澤 淳; 津田 真弘; 今井 哲司; 池見 泰明; 大村 友博; 中川 俊作; 中川 貴之; 矢野 育子; 松原 和夫

  JSBMS Letters, Aug. 2017

  
• リツキシマブの体内動態とその変動因子の考察

  大谷祐基; 米澤淳; 礒本唯; 津田真弘; 池見泰明; 今井哲司; 大村友博; 中川俊作; 中川貴之; 矢野育子; 北野俊行; 高折晃史; 松原和夫

  医療薬学フォーラム講演要旨集, Jun. 2017

  
• 生体肝移植術後のタクロリムス静脈内投与から経口投与への切り替え換算量に関する検討

  都築 徹教; 矢野 育子; 中川 俊作; 杉本 充弘; 佐藤 裕紀; 津田 真弘; 上杉 美和; 岡島 英明; 海道 利実; 上本 伸二; 松原 和夫

  TDM研究, May 2016

  
• シクロスポリンおよびタクロリムスの血中濃度測定系に対するアゾール系抗真菌薬の影響

  岩上 智香; 津田 真弘; 杉本 充弘; 米澤 淳; 都築 徹教; 松原 惇起; 中川 俊作; 矢野 育子; 中川 貴之; 松原 和夫

  日本薬学会年会要旨集, Mar. 2016

  
• インフリキシマブ先行品と後続品における糖鎖構造の比較

  津田 真弘; 大谷 祐基; 米澤 淳; 池見 泰明; 大村 友博; 中川 俊作; 今井 哲司; 中川 貴之; 矢野 育子; 松原 和夫

  日本薬学会年会要旨集, Mar. 2016

  
• Anti-multiple myeloma drug-associated taste dysfunction: An analysis of the FAERS database

  Ayano Inoba; Kaori Kadoyama; Keiko Minami; Akiko Tamon; Masahiro Tsuda; Toshiyuki Sakaeda; Yasushi Okuno

  Asian Journal of Pharmaceutical Sciences, 01 Feb. 2016

  Access this misc :

  
• アファチニブ治療における治療継続と有害反応重篤化回避に対する継続的介入の重要性

  山嶋仁実; 寺尾真琴; 池見泰明; 津田真弘; 津田真弘; 今井哲司; 永井宏樹; 永井宏樹; 松原和夫

  日本医療薬学会年会講演要旨集(Web), 2016

  
• 生体肝移植術後のタクロリムス静脈内導入における点滴速度の適正化

  都築 徹教; 矢野 育子; 中川 俊作; 津田 真弘; 上杉 美和; 杉本 充弘; 岡島 英明; 海道 利実; 上本 伸二; 松原 和夫

  移植, Sep. 2015

  
• 血液・リンパ リンパ腫治療の将来展望 生体内におけるリツキシマブの経時的構造変化の解析

  大谷 祐基; 米澤 淳; 今井 哲司; 津田 真弘; 兼吉 真千子; 池見 泰明; 大村 友博; 中川 俊作; 矢野 育子; 北野 俊行; 高折 晃史; 松原 和夫

  日本癌治療学会誌, Sep. 2015

  
• 新規抗てんかん薬の使用状況と血中濃度モニタリングの実際

  SATO AYUKO; TSUDA MASAHIRO; TSUZUKI TETSUNORI; SUGIMOTO MITSUHIRO; YANO IKUKO; NAKAGAWA TAKAYUKI; MATSUBARA KAZUO

  TDM研究, 15 May 2015

  
• 生体肝移植術後のタクロリムス静脈内導入における血中濃度の評価

  TSUZUKI TETSUNORI; YANO IKUKO; NAKAGAWA SHUNSAKU; TSUDA MASAHIRO; UESUGI MIWA; SUGIMOTO MITSUHIRO; KAIDO TOSHIMI; UEMOTO SHINJI; MATSUBARA KAZUO

  TDM研究, 15 May 2015

  
• リツキシマブの生体内における構造変化の評価

  大谷 祐基; 米澤 淳; 今井 哲司; 津田 真弘; 池見 泰明; 大村 友博; 中川 俊作; 中川 貴之; 松原 和夫

  日本薬剤学会年会講演要旨集, May 2015

  
• プロトコルに基づいた薬物治療管理が臨床アウトカムに与える影響:TDMオーダを含めた処方設計支援

  KATADA YOSHIKI; NAKAGAWA SHUNSAKU; TAGAMI YUMI; TSUDA MASAHIRO; TSUZUKI TETSUNORI; ODAKA MIZUHO; YONEZAWA ATSUSHI; KAYANO YUICHIRO; YANO IKUKO; MINAKATA KENJI; SAKATA RYUZO; MATSUBARA KAZUO

  日本薬学会年会要旨集(CD-ROM), Mar. 2015

  
• 生体肝移植後C型肝炎再燃に対するシメプレビル+ペグインターフェロン+リバビリン療法の治療効果とタクロリムス血中濃度への影響

  TSUZUKI TETSUNORI; NAKAGAWA SHUNSAKU; TSUDA MASAHIRO; UESUGI MIWA; YANO IKUKO; MATSUBARA KAZUO; UEDA YOSHIHIDE; CHIBA TSUTOMU; KAIDO TOSHIMI; UEMOTO SHINJI

  日本薬学会年会要旨集(CD-ROM), Mar. 2015

  
• 21-5-O6-07 FDA大規模有害事象自発報告データベースを用いた多発性骨髄腫治療薬投与に伴う味覚障害の解析(有害事象・副作用,口頭発表,一般演題,医療薬学の進歩と未来-次の四半世紀に向けて-)

  井野場 郁乃; 角山 香織; 南 景子; 多門 啓子; 津田 真弘; 栄田 敏之; 奥野 恭史

  日本医療薬学会年会講演要旨集, 2015

  
• 薬剤師による処方設計(29)外来がん化学療法におけるトレーシングレポートを活用した病診薬連携の取り組み

  津田 真弘; 礒本 唯; 萱野 勇一郎

  医薬ジャーナル, Nov. 2014

  
• B型肝炎ウイルス再活性化のリスク低減への取り組み:ガイドライン基づく検査の実施率向上の工夫

  MATSUMURA YUMI; UEDA YOSHIHIDE; TSUDA MASAHIRO; TAKAKURA SHUNJI; OKAMOTO KAZUNARI

  医療の質・安全学会誌, 31 Oct. 2014

  
• 薬剤師不在の過疎地域病院への薬剤師派遣による医療支援の試み

  ISHIBASHI NAOYA; TSUDA MASAHIRO; SATO YUKI; IKEMI YASUAKI; MATSUDA YUYA; HATTA MANAMI; KOEDA MASAYOSHI; TAKAHASHI KAZUYA; OHARA YUKI; SHIGA HIROYASU; NAKAGAWA SHUNSAKU; FUKATSU YOSHIHIRO; YONEZAWA ATSUSHI; TASAKI YOSHIKAZU; MIYAMOTO ATSUSHI; ISEKI KEN; SHIRAI MASANOBU; MATSUBARA KAZUO

  日本医療薬学会年会講演要旨集, 25 Aug. 2014

  
• B型肝炎ウイルス再活性化初期スクリーニング検査の実施状況調査

  SHIMIZU MICHIKO; TSUDA MASAHIRO; IKEMI YASUAKI; FUKATSU YOSHIHIRO; ISHIZUKA YOSHIKO; YONEZAWA ATSUSHI; MATSUMURA YUMI; MATSUBARA KAZUO

  日本医療薬学会年会講演要旨集, 25 Aug. 2014

  
• LC/TOF‐MSを用いた抗体医薬品の糖鎖解析

  OTANI YUKI; MATSUMURA KENGO; YONEZAWA ATSUSHI; OMURA TOMOHIRO; TSUDA MASAHIRO; NAKAGAWA TAKAYUKI; MATSUBARA KAZUO

  日本医療薬学会年会講演要旨集, 25 Aug. 2014

  
• LC/TOF‐MSによるG‐CSFバイオ後続品の定性分析

  MATSUMURA KENGO; OTANI YUKI; OMURA TOMOHIRO; YONEZAWA ATSUSHI; TSUDA MASAHIRO; YOSHIKI TATSUHIRO; MATSUBARA KAZUO

  日本医療薬学会年会講演要旨集, 25 Aug. 2014

  
• 当院における頭頸部がんに対するセツキシマブ併用化学放射線治療時の疼痛コントロールの現状

  森 由希子; 角 裕子; 祝 千佳子; 津田 真弘; 井沢 知子; 大浦 邦康; 小林 正行; 林 晶子; 武藤 学

  日本緩和医療学会学術大会プログラム・抄録集, Jun. 2014

  
• セツキシマブ併用放射線療法による粘膜皮膚炎に対する疼痛コントロールの現状

  KADO YUKO; KOBAYASHI MASAYUKI; HAYASHI AKIKO; MORI YUKIKO; IWAI CHIKAKO; TSUDA MASAHIRO

  日本緩和医療学会学術大会プログラム・抄録集, Jun. 2014

  
• がん領域におけるプレガバリン使用実態に基づく効果と副作用に関する調査

  IWAI CHIKAKO; YANO IKUKO; TSUDA MASAHIRO; NAKAGAWA TAKAYUKI; MATSUBARA KAZUO

  日本癌治療学会学術集会(CD-ROM), Jun. 2014

  
• 腎がん患者におけるエベロリムスの使用実態に関する調査

  NIISAKO KEIKO; YANO IKUKO; TANAKA ATSUKO; FUKUDO MASAHIDE; TSUDA MASAHIRO; KATADA YOSHIKI; NAKAISHI MAYUMI; KOBAYASHI YASUSHI; OKUBO KAZUTOSHI; KAMBA TOMOMI; YOSHIMURA KOJI; OGAWA OSAMU; MATSUBARA KAZUO

  日本医療薬学会年会講演要旨集, 28 Aug. 2013

  
• 新規抗凝固薬ダビガトランの出血性副作用発現因子の探索

  KIMURA YOSHIHIKO; ONOUE MASAHIDE; KAWADA MASAYOSHI; HASHIMOTO EMINA; OGATA AKIRA; TSUDA MASAHIRO; YOSHINO HIDEKI; SAZAWA MIZUHO; MORITA YOSUKE; MASUDA SATOHIRO; YANO IKUKO; MATSUBARA KAZUO

  日本医療薬学会年会講演要旨集, 10 Oct. 2012

  
• がん化学療法レジメンにおける制吐薬の標準化に向けた取り組み

  TSUDA MASAHIRO; KOBAYASHI MASAHIKO; ISHIBASHI NAOYA; KINOSHITA RISA; KATSURA TOSHIYA; YANAGIHARA KAZUHIRO; TOI MASAKAZU; MATSUBARA KAZUO

  日本癌治療学会学術集会(CD-ROM), Oct. 2012

  
• 腎細胞がんおよび肝細胞がん患者におけるソラフェニブの母集団薬物動態解析

  MIZUNO TOMOYUKI; FUKUDO MASAHIDE; TERADA TOMOHIRO; KUNIMATSU SACHIKO; NIISAKO KEIKO; TSUDA MASAHIRO; HATANO ETSURO; UEMOTO SHINJI; KAMBA TOMOMI; NAKAMURA EIJIRO; OGAWA OSAMU; SENOO HIROSHI; CHIBA TSUTOMU; INUI KEN'ICHI; KATSURA TOSHIYA

  日本薬剤学会年会講演要旨集(Web), 25 Apr. 2012

  
• Disruption of multidrug and toxin extrusion 1 (MATE1) causes metformin-induced lactic acidosis

  Kana Toyama; Atsushi Yonezawa; Masahiro Tsuda; Tomohiro Terada; Toshiya Katsura; Ken-ichi Inui

  DRUG METABOLISM REVIEWS, May 2011

  
• H+/有機カチオンアンチポータMATEの遺伝子多型によるメトホルミンの体内動態変化

  遠山 佳奈; 米澤 淳; 津田 真弘; 増田 智先; 矢野 育子; 大澤 理代; 細川 雅也; 藤本 新平; 稲垣 暢也; 桂 敏也; 乾 賢一

  臨床薬理, Nov. 2010

  
• Role of H+/Organic Cation Antiporter MATE1/SLC47A1 in the Renal Tubular Secretion of Metformin and Cephalexin

  Masahiro Tsuda; Shingo Watanabe; Atsushi Yonezawa; Tomohiro Terada; Satohiro Masuda; Toshiya Katsura; Ken-ichi Inui

  DRUG METABOLISM REVIEWS, Aug. 2010

  
• 両性イオン型薬物セファレキシンの腎排泄におけるMATE1の役割

  WATANABE SHINGO; TERADA TOMOHIRO; TSUDA MASAHIRO; KATSURA TOSHIYA; INUI KEN'ICHI

  薬剤学, 20 Apr. 2010

  
• 薬物腎排泄におけるH⁺/有機カチオンアンチポータ(MATE1)の役割

  TERADA TOMOHIRO; TSUDA MASAHIRO; KATSURA TOSHIYA; INUI KEN'ICHI

  膜シンポジウム, 10 Nov. 2009

  
• ビンカアルカロイド系抗がん剤の物理化学的特性に及ぼす温度変化の影響

  小島 一晃; 寺田 智祐; 津田 真弘; 橋田 亨; 矢野 育子; 乾 賢一

  日本病院薬剤師会雑誌, May 2009

  
• COMPARISON OF DRIVING FORCE AND SUBSTRATE AFFINITY OF H+/ORGANIC CATION ANTIPORTERS MATE1 AND MATE2-K

  Masahiro Tsuda; Tomohiro Terada; Miki Ueba; Toshiya Katsura; Ken-ichi Inui

  JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009

  
• 温度変化に対するビンカアルカロイド系抗がん剤の物理化学的特性の検討

  KOJIMA KAZUAKI; TERADA TOMOHIRO; TSUDA MASAHIRO; HASHIDA TOORU; YANO IKUKO; INUI KEN'ICHI

  日本医療薬学会年会講演要旨集, 01 Sep. 2008

  
• 腎有機カチオン輸送系の親和性の比較に基づいた薬物相互作用の評価

  TSUDA MASAHIRO; TERADA TOMOSUKE; SATO TOMOKO; MASUDA TOMOSAKI; KATSURA TOSHIYA; INUI KEN'ICHI

  薬剤学, 30 Apr. 2008

  
• H⁺/有機カチオンアンチポータMATE1の輸送機能解析と駆動力の同定

  TSUDA MASAHIRO; UEBA MIKI; TERADA TOMOHIRO; KATSURA TOSHIYA; INUI KEN'ICHI

  日本膜学会年会講演要旨集, 30 Apr. 2007

  
• H+/有機カチオンアンチポータ(MATE)の輸送活性を規定するアミノ酸残基の同定

  寺田 智祐; 朝賀 純一; 津田 真弘; 桂 敏也; 乾 賢一

  日本腎臓学会誌, Apr. 2007

  
• H⁺/有機カチオンアンチポータMATEの必須cysteine残基の同定

  TOMOGA JUN'ICHI; TERADA TOMOSUKE; TSUDA MASAHIRO; KATSURA TOSHIYA; INUI KEN'ICHI

  日本薬学会年会要旨集, 05 Mar. 2007

  
• H+/有機カチオンアンチポータMATEの必須cysteine残基の同定

  朝賀 純一; 寺田 智祐; 津田 真弘; 桂 敏也; 乾 賢一

  日本薬学会年会要旨集, Mar. 2007

  
• 低血圧症治療薬ミドドリンの消化管吸収におけるペプチドトランスポータPEPT1の役割

  TERADA TOMOSUKE; TSUDA MASAHIRO; KATSURA TOSHIYA; INUI KEN'ICHI

  日本膜学会年会講演要旨集, 02 Jun. 2006

  
• ラットH+/有機カチオン逆輸送体(rMATE1)の遺伝子クローニングと機能解析

  寺田 智祐; 増田 智先; 朝賀 純一; 津田 真弘; 桂 敏也; 乾 賢一

  日本腎臓学会誌, Apr. 2006

  
• H+駆動型ペプチドトランスポータ(PEPT1)発現量の異なるヒト培養腸上皮細胞Caco-2におけるglycylsarcosine輸送の予測

  津田 真弘; 入江 めぐみ; 寺田 智祐; 桂 敏也; 乾 賢一

  日本薬学会年会要旨集, Mar. 2006

  
• Functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1

  Jun-ichi Asaka; Tomohiro Terada; Satohiro Masuda; Masahiro Tsuda; Toshiya Katsura; Ken-ichi Inui

  DRUG METABOLISM REVIEWS, 2006

  

Books and Other Publications

• 循環器疾患最新の治療2022-2023

  伊藤, 浩; 山下, 武志, Contributor, 循環器疾患の薬物一覧

  南江堂, Jan. 2022

  Find Kyoto University's collection of books :

  
• 循環器疾患最新の治療2020-2021

  安田 寿一; 杉本 恒明; 篠山 重威; 矢崎 義雄; 堀 正二; 永井 良三; 伊藤 浩; 山下 武志, Contributor, 循環器疾患の薬物一覧

  南江堂, Jan. 2020

  
• 患者の語りと医療者教育 : "映像と言葉"が伝える当事者の経験

  健康と病いの語りディペックス・ジャパン, Contributor, 9. 医療・生命倫理における「語り」を活用したディープ・アクティブラーニング ー薬学教育における「薬学研究SGD演習」

  日本看護協会出版会, Dec. 2019

  Find Kyoto University's collection of books :

  
• 循環器疾患 最新の治療2018-2019

  津田 真弘, Contributor, 循環器疾患の薬物一覧

  南江堂, Jan. 2018, Not refereed

  
• 循環器疾患 最新の治療2016-2017

  津田 真弘, Contributor, 循環器疾患の薬物一覧

  南江堂, Mar. 2016, Not refereed

  
• 第十七改正日本薬局方解説書

  津田 真弘, Contributor, 医薬品各条 服薬指導

  廣川書店, 2016, Not refereed

  

External funds: Kakenhi

• Development of a microfluidic device that mimics inflammatory bowel disease caused by disruption of the intestinal flora

  Grant-in-Aid for Scientific Research (C)

  Basic Section 47060:Clinical pharmacy-related

  Kyoto University

  津田 真弘

  From 01 Apr. 2021, To 31 Mar. 2024, Granted

  腸内細菌叢;マイクロ流体デバイス;Organ-on-a-chip;炎症性腸疾患;腸管免疫;Disease-on-a-chip;Gut-on-a-chip;共培養

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K06642/
• Establishment of appropriate management of anti-HIV drugs to suppress the onset of HIV-associated neurocognitive disorder (HAND)

  Grant-in-Aid for Scientific Research (C)

  Basic Section 47060:Clinical pharmacy-related

  Kyoto University

  Masahiro Tsuda

  From 01 Apr. 2018, To 31 Mar. 2021, Project Closed

  抗HIV薬;インテグラーゼ阻害薬;トランスポーター;BCRP;P-gp;血液脳関門;HIV関連神経認知障害;有害事象自発報告データベース;脂溶性;脳移行;トランスポータ;HAND

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K06747/
• Pharmacokinetic analysis for TDM of anti-HIV drug dolutegravir.

  Grant-in-Aid for Young Scientists (B)

  Kyoto University

  Masahiro Tsuda

  From 01 Apr. 2016, To 31 Mar. 2018, Project Closed

  抗HIV薬;TDM;薬物動態;個別化医療;エイズ;LC/MS/MS;アドヒアランス;トランスポータ

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K18938/
• Correlation analysis between glycosylation and the efficacy of antibody preparation in human blood

  Grant-in-Aid for Young Scientists (B)

  Kyoto University

  Masahiro TSUDA

  From 01 Apr. 2014, To 31 Mar. 2016, Project Closed

  抗体;糖鎖;癌;質量分析;バイオテクノロジー;薬物動態;血中濃度;翻訳後修飾

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26860102/

Education

Teaching subject(s)

• From 01 Apr. 2024, To 31 Mar. 2025

  Introduction to Pharmaceutical Sciences and Ethics

  U129, Spring, Institute for Liberal Arts and Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Laboratory Practice in Clinical Pharmacy I

  6301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Laboratory Practice in Basic Clinical Pharmacy

  4211, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Laboratory Practice in Clinical Pharmacy II

  6302, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  実務実習

  B998, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2024, To 31 Mar. 2025

  国試連絡用

  B997, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2024, To 31 Mar. 2025

  共用試験関係

  B999, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Clerkship in Hospital Pharmacy

  E901, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2024, To 31 Mar. 2025

  Clinical Clerkship in Hospital Pharmacy

  B901, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2024, To 31 Mar. 2025

  SGD Classes for Pharmaceutical Research

  C501, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Therapeutic Pharmacology 1

  A308, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Community Clinical Pharmacy

  C317, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Therapeutic Pharmacology

  C308, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Community Clinical Pharmacy1

  B309, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar for Clinical Pharmacy II

  6102, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar for Clinical Pharmacy I

  6101, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar in Basic Clinical Pharmacy

  2313, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar for Clinical Pharmacy III

  6103, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Research in Pharmaceutical Sciences I

  6201, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Research in Basic Clinical Pharmacy

  3213, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Research in Pharmaceutical Sciences III

  6203, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Research in Pharmaceutical Sciences II

  6202, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Introduction to Pharmaceutical Sciences and Ethics

  U129, Spring, Institute for Liberal Arts and Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Laboratory Practice in Clinical Pharmacy II

  6302, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Laboratory Practice in Clinical Pharmacy I

  6301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  共用試験関係

  B999, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2023, To 31 Mar. 2024

  実務実習

  B998, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2023, To 31 Mar. 2024

  国試連絡用

  B997, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2023, To 31 Mar. 2024

  Clinical Clerkship in Hospital Pharmacy

  E901, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Training(Clinical Pharmacy and Education)

  D162, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2023, To 31 Mar. 2024

  Clinical Clerkship in Hospital Pharmacy

  B901, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Training(Clinical Pharmacy and Education)

  B820, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Training(Clinical Pharmacy and Education)

  E819, Year-long, Faculty of Pharmaceutical Sciences, 14
• From 01 Apr. 2023, To 31 Mar. 2024

  Research in Pharmaceutical Sciences III

  6203, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Research in Pharmaceutical Sciences II

  6202, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Research in Pharmaceutical Sciences I

  6201, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar for Clinical Pharmacy II

  6102, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar for Clinical Pharmacy I

  6101, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Advanced Hospital Pharmacy

  6008, Fall, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar for Clinical Pharmacy III

  6103, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  SGD Classes for Pharmaceutical Research

  C501, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Therapeutic Pharmacology

  C308, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Therapeutic Pharmacology 1

  A308, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Community Clinical Pharmacy1

  B309, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  実務実習

  B998, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2022, To 31 Mar. 2023

  Clinical Clerkship in Hospital Pharmacy

  E901, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2022, To 31 Mar. 2023

  Medical Sociology

  C313, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  国試連絡用

  B997, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2022, To 31 Mar. 2023

  Clinical Pharmacy 1

  A313, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical R&D Exercise II

  A405, Spring, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Clinical Clerkship in Community Pharmacy

  E902, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2022, To 31 Mar. 2023

  共用試験関係

  B999, Year-long, Faculty of Pharmaceutical Sciences, 0
• From 01 Apr. 2022, To 31 Mar. 2023

  Clinical Clerkship in Hospital Pharmacy

  B901, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2022, To 31 Mar. 2023

  Laboratory for medical ethics

  A407, Fall, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Pre-Training for Clinical Clerkship

  B354, Fall, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Clinical Clerkship in Community Pharmacy

  B902, Year-long, Faculty of Pharmaceutical Sciences, 10
• From 01 Apr. 2022, To 31 Mar. 2023

  SGD Classes for Pharmaceutical Research

  C501, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical R&D Exercise 2

  C405, Spring, Faculty of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Community Clinical Pharmacy

  C317, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Pre-Training for Clinical Clerkship

  E354, Fall, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Community Clinical Pharmacy2

  B310, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Interprofessional Clinical Exposure

  C407, Spring, Faculty of Pharmaceutical Sciences, 1
• From Apr. 2015, To Mar. 2016

  Research Training(Education of Clinical Pharmacy)

  Year-long, 薬学部
• From Apr. 2016, To Mar. 2017

  Frontier SGD Classes for Clinical Pharmacy

  Spring, 薬学部
• From Apr. 2016, To Mar. 2017

  Laboratory for medical ethics

  Fall, 薬学部
• From Apr. 2016, To Mar. 2017

  Pre-Training for Clinical Clerkship

  Year-long, 薬学部
• From Apr. 2016, To Mar. 2017

  Pharmaceutical R&D Exercise II

  Spring, 薬学部
• From Apr. 2016, To Mar. 2017

  Community Clinical Pharmacy1

  Spring, 薬学部
• From Apr. 2016, To Mar. 2017

  Research Training(Education of Clinical Pharmacy)

  Year-long, 薬学部
• From Apr. 2016, To Mar. 2017

  Clinical Clerkship in Hospital Pharmacy

  Year-long, 薬学部
• From Apr. 2016, To Mar. 2017

  Clinical Clerkship in Community Pharmacy

  Year-long, 薬学部
• From Apr. 2017, To Mar. 2018

  Frontier SGD Classes for Clinical Pharmacy

  Spring, 薬学部
• From Apr. 2017, To Mar. 2018

  Laboratory for medical ethics

  Fall, 薬学部
• From Apr. 2017, To Mar. 2018

  Pre-Training for Clinical Clerkship

  Year-long, 薬学部
• From Apr. 2017, To Mar. 2018

  Pharmaceutical R&D Exercise II

  Spring, 薬学部
• From Apr. 2017, To Mar. 2018

  Community Clinical Pharmacy1

  Spring, 薬学部
• From Apr. 2017, To Mar. 2018

  Clinical Clerkship in Hospital Pharmacy

  Year-long, 薬学部
• From Apr. 2017, To Mar. 2018

  Clinical Clerkship in Community Pharmacy

  Year-long, 薬学部
• From Apr. 2018, To Mar. 2019

  共用試験関係

  Year-long, 薬学部
• From Apr. 2018, To Mar. 2019

  Laboratory for medical ethics

  Fall, 薬学部
• From Apr. 2018, To Mar. 2019

  Pre-Training for Clinical Clerkship

  Fall, 薬学部
• From Apr. 2018, To Mar. 2019

  Pharmaceutical R&D Exercise II

  Spring, 薬学部
• From Apr. 2018, To Mar. 2019

  Community Clinical Pharmacy1

  Spring, 薬学部
• From Apr. 2018, To Mar. 2019

  Community Clinical Pharmacy2

  Spring, 薬学部
• From Apr. 2018, To Mar. 2019

  Interprofessional Clinical Exposure

  Spring, 薬学部
• From Apr. 2018, To Mar. 2019

  実務実習

  Year-long, 薬学部
• From Apr. 2018, To Mar. 2019

  Clinical Clerkship in Hospital Pharmacy

  Year-long, 薬学部
• From Apr. 2018, To Mar. 2019

  SGD Classes for Pharmaceutical Research

  Spring, 薬学部
• From Apr. 2018, To Mar. 2019

  Clinical Clerkship in Community Pharmacy

  Year-long, 薬学部
• From Apr. 2019, To Mar. 2020

  共用試験関係

  Year-long, 薬学部
• From Apr. 2019, To Mar. 2020

  Laboratory for medical ethics

  Fall, 薬学部
• From Apr. 2019, To Mar. 2020

  Pre-Training for Clinical Clerkship

  Fall, 薬学部
• From Apr. 2019, To Mar. 2020

  Pharmaceutical R&D Exercise II

  Spring, 薬学部
• From Apr. 2019, To Mar. 2020

  Community Clinical Pharmacy1

  Spring, 薬学部
• From Apr. 2019, To Mar. 2020

  Community Clinical Pharmacy2

  Spring, 薬学部
• From Apr. 2019, To Mar. 2020

  Basic Clinical Research

  Fall, 薬学部
• From Apr. 2019, To Mar. 2020

  Interprofessional Clinical Exposure

  Spring, 薬学部
• From Apr. 2019, To Mar. 2020

  実務実習

  Year-long, 薬学部
• From Apr. 2019, To Mar. 2020

  Clinical Clerkship in Hospital Pharmacy

  Year-long, 薬学部
• From Apr. 2019, To Mar. 2020

  SGD Classes for Pharmaceutical Research

  Spring, 薬学部
• From Apr. 2019, To Mar. 2020

  Clinical Clerkship in Community Pharmacy

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  Pharmaceutical Common Achievement Tests

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  Laboratory for medical ethics

  Fall, 薬学部
• From Apr. 2020, To Mar. 2021

  Pre-Training for Clinical Clerkship

  Fall, 薬学部
• From Apr. 2020, To Mar. 2021

  Pharmaceutical R&D Exercise II

  Spring, 薬学部
• From Apr. 2020, To Mar. 2021

  国試連絡用

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  Community Clinical Pharmacy1

  Spring, 薬学部
• From Apr. 2020, To Mar. 2021

  Community Clinical Pharmacy2

  Spring, 薬学部
• From Apr. 2020, To Mar. 2021

  Community Clinical Pharmacy

  Spring, 薬学部
• From Apr. 2020, To Mar. 2021

  Basic Clinical Research

  Fall, 薬学部
• From Apr. 2020, To Mar. 2021

  Interprofessional Clinical Exposure

  Spring, 薬学部
• From Apr. 2020, To Mar. 2021

  実務実習（病３薬２）

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  実務実習（病２薬１）

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  実務実習（病４薬３）

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  Clinical Clerkship in Hospital Pharmacy

  Year-long, 薬学部
• From Apr. 2020, To Mar. 2021

  SGD Classes for Pharmaceutical Research

  Spring, 薬学部
• From Apr. 2020, To Mar. 2021

  Clinical Clerkship in Community Pharmacy

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  ILAS Seminar :Pharmaceuticals and Medicine

  Spring, 全学共通科目
• From Apr. 2021, To Mar. 2022

  Pharmaceutical Common Achievement Tests

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  Laboratory for medical ethics

  Fall, 薬学部
• From Apr. 2021, To Mar. 2022

  Pre-Training for Clinical Clerkship

  Fall, 薬学部
• From Apr. 2021, To Mar. 2022

  Pre-Training for Clinical Clerkship

  Fall, 薬学部
• From Apr. 2021, To Mar. 2022

  Medical Sociology

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Clinical Pharmacy 1

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Pharmaceutical R&D Exercise 2

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Pharmaceutical R&D Exercise II

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  国試連絡用

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  Community Clinical Pharmacy1

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Community Clinical Pharmacy2

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Community Clinical Pharmacy

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Basic Clinical Research

  Fall, 薬学部
• From Apr. 2021, To Mar. 2022

  Interprofessional Clinical Exposure

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  実務実習（薬２病３）

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  実務実習（薬１病２）

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  実務実習（薬３病４）

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  Clinical Clerkship in Hospital Pharmacy

  Year-long, 薬学部
• From Apr. 2021, To Mar. 2022

  SGD Classes for Pharmaceutical Research

  Spring, 薬学部
• From Apr. 2021, To Mar. 2022

  Clinical Clerkship in Community Pharmacy

  Year-long, 薬学部

Administration

Faculty management (title, position)

• From 01 Apr. 2023, To 31 Mar. 2025

  情報システム委員会　委員
• From 01 Apr. 2023, To 31 Mar. 2025

  教務委員会　委員
• From 01 Apr. 2022, To 31 Mar. 2025

  DEI推進委員会　委員
• From 01 Apr. 2015, To 31 Mar. 2025

  図書委員会　委員
• From 01 Apr. 2015, To 31 Mar. 2025

  建物・設備・機器管理運営委員会　委員
• From 01 Apr. 2015, To 31 Mar. 2022

  教務委員会　委員
• From 01 Apr. 2017, To 31 Mar. 2025

  環境・安全衛生委員会委員
• From 01 Apr. 2019, To 31 Mar. 2023

  実務実習委員会 委員